C

Cydan

12 employees

Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Medical

Date founded

2013

Funding rounds raised

Total raised

$34M

from 4 investors over 4 rounds

C

Cydan raised $34M on October 17, 2017

Investors: Longitude Capital and Lundbeckfonden / Lundbeck Foundation

C

Cydan raised $10M on October 1, 2013

Investors: Lundbeckfonden / Lundbeck Foundation and Bay City Capital

FAQ